Nov 1, 2024, 15:51
Simon Crompton explores why it is so hard to do head-to-head trials – SPCC
SPCC (Sharing Progress in Cancer Care) shared a recent article by Simon Crompton on LinkedIn:
“In cancers traditionally treated by either surgery or radiotherapy, barriers to testing their comparative efficacy and safety leaves patients unable to make informed choices.
Simon Crompton explores why it is so hard to do head-to-head trials, and reports on the data sets generated during the pandemic that could provide some answers.”
Auother: Simon Crompton
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 3, 2024, 08:05
Dec 3, 2024, 05:43
Dec 3, 2024, 05:40
Dec 3, 2024, 05:36
Dec 3, 2024, 05:11
Dec 3, 2024, 05:06
Dec 3, 2024, 05:01
Dec 3, 2024, 04:55
Dec 3, 2024, 04:51
Dec 3, 2024, 03:59
Dec 3, 2024, 03:53